Petros Pharmaceuticals, Inc. (PTPI): auditor change — Petros Pharmaceuticals terminates Marcum as auditor, engages CBIZ; prior reports include going concern

Petros Pharmaceuticals, Inc.

Company terminated Marcum LLP as auditor on April 5, 2025, and engaged CBIZ CPAs P.C. as new independent auditor for FY 2025.
No disagreements or reportable events except a material weakness in internal controls over financial reporting disclosed in 2024 10-K.
Marcum's reports for FY 2023 and 2024 included an explanatory paragraph about substantial doubt as a going concern.
Marcum provided a letter to SEC dated April 9, 2025, agreeing with the company's statements (Exhibit 16.1 filed).

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Petros Pharmaceuticals, Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

the Company terminated its relationship with Marcum as the Company’s independent registered accounting firm

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Petros Pharmaceuticals, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

engaged CBIZ CPAs as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025

View on SEC.gov

Browse all auditor changes →

Petros Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-033391

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.